杨梅素对人卵巢癌SKOV3细胞的凋亡诱导作用
[Abstract]:Aim: to investigate the effect of myricetin on the growth inhibition and apoptosis induction of human ovarian cancer SKOV3 cells and its possible mechanism. Methods: human ovarian cancer SKOV3 cells were cultured in vitro. The cells were divided into two groups according to the concentration of myricetin: control group and low concentration group. The survival rate of SKOV3 cells was detected by 60mg L-1.MTT method. The morphologic changes of SKOV3 nuclei were observed by laser confocal microscope and the abnormal nuclear ratio was calculated. The expression of apoptosis-related protein-activated cysteine protease 3 (active Caspase-3) in SKOV3 cells was detected by immunofluorescence assay. The expression of DNA damage associated protein 纬 -H2AX in SKOV3 cells was detected by; Western blotting method. Results: compared with the control group, the survival rate of SKOV3 cells in the myricetin group was significantly lower than that in the control group (P 0.05), and the apoptotic morphologic changes such as nuclear shrinkage were observed in the myricetin group with laser confocal microscope, and the survival rate of the cells in the myricetin group was significantly lower than that in the control group (P 0.05). The percentage of abnormal nuclei in the cells was higher than that in the control group (t = 6.87), and the ratio of abnormal nuclei in the high concentration group was higher than that in the control group (P 0.05). The expression of active Caspase-3 in SKOV3 cells showed a tendency to increase with the increase of the administration concentration of myricetin, and the ratio of abnormal nuclei in the medium concentration group was higher than that in the control group. The expression level of 纬-H2AX in SKOV3 cells of myricetin group was higher than that in control group. Conclusion: myricetin can inhibit the proliferation and induce apoptosis of human ovarian cancer SKOV3 cells, and DNA double strand break may be one of its mechanisms.
【作者单位】: 吉林医药学院基础医学院实验中心;吉林医药学院检验学院;吉林大学基础医学院病理生理学系;吉林省吉林中西医结合医院体检中心;吉林医药学院临床医学院;
【基金】:国家自然科学基金面上项目资助课题(81372793) 吉林省教育厅十二五科技项目资助课题(2013361) 吉林省大学生创新创业项目资助课题(20141027)
【分类号】:R737.31
【参考文献】
相关期刊论文 前6条
1 刘燕妮;童文聪;庞会芳;练娟娟;;宫颈癌的流行情况调查与诊疗[J];当代医学;2011年12期
2 林国钡;谢燕;李国文;;杨梅素的研究进展[J];国际药学研究杂志;2012年06期
3 梁馨予;张婷;周永;施琳颖;陈军丽;王丽;康超;朱俊东;糜漫天;;杨梅素减轻高糖诱导的血管内皮细胞氧化应激损伤[J];第三军医大学学报;2013年21期
4 郭海清;任锋;陈亚利;张向颖;段钟平;孙华;张晶;;杨梅素对HepG2细胞凋亡的影响[J];北京医学;2014年09期
5 李留霞;李冰熠;李秀芳;张兰兰;王凯娟;张建营;;上皮性卵巢癌组织中IMP1的表达[J];郑州大学学报(医学版);2014年03期
6 杨香丽;黄冬梅;孙欣欣;;卵巢癌术后2种治疗方案疗效分析[J];郑州大学学报(医学版);2014年04期
【共引文献】
相关期刊论文 前10条
1 李萍;彭莉;;顺铂联合5-氟尿嘧啶在晚期宫颈癌治疗中的临床疗效[J];当代医学;2011年19期
2 赵政敏;徐滕滕;;宫颈癌患者围手术期舒适护理中的临床效果[J];中国医药科学;2013年09期
3 刘同方;于华忠;陈雁梅;高梦;郑红岩;刘建兰;;杨梅素植物来源及提取分离方法研究进展[J];安徽农业科学;2014年15期
4 郭海清;任锋;陈亚利;张向颖;段钟平;孙华;张晶;;杨梅素对HepG2细胞凋亡的影响[J];北京医学;2014年09期
5 汤凯雯;陈历排;杜佩妍;吴蕴瑜;;化疗联合顺铂腹腔热灌注治疗中晚期卵巢癌术后的效果[J];广东医学;2015年11期
6 王敏;;顺铂联合5-Fu治疗晚期宫颈癌近期疗效观察[J];医药论坛杂志;2013年07期
7 刘涛;龙本文;罗欢;金吉芬;解璞;彭志军;;荸荠杨梅的挥发油成分分析[J];化学试剂;2014年09期
8 王石秀;况荣华;傅颖s,
本文编号:2280520
本文链接:https://www.wllwen.com/yixuelunwen/fuchankeerkelunwen/2280520.html